Viridian Therapeutics, Inc. Profile Avatar - Palmy Investing

Viridian Therapeutics, Inc.

Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye…

Biotechnology
US, Waltham [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of VRDN's Analysis
CIK: 1590750 CUSIP: 92790C104 ISIN: US92790C1045 LEI: - UEI: -
Secondary Listings
VRDN has no secondary listings inside our databases.